Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial. - Wikidata - wikimedia - TriplyDB

Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial.

Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial.

http://www.wikidata.org/entity/Q47968070

about

Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials Heart Failure: Diagnosis, Management and Utilization Present and future pharmacotherapeutic agents in heart failure: an evolving paradigm Reliable and effective oxygen-ozone therapy at a crossroads with ozonated saline infusion and ozone rectal insufflation.Heart failure and chronic obstructive pulmonary disease: Two for tea or tea for two?Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair.Oxygen/ozone as a medical gas mixture. A critical evaluation of the various methods clarifies positive and negative aspects.Red cell distribution width is an independent factor for left ventricular diastolic dysfunction in patients with chronic kidney disease Red Blood Cell Distribution Width is Independently Correlated With Diurnal QTc Variation in Patients With Coronary Heart Disease Myeloid-Epithelial-Reproductive Receptor Tyrosine Kinase and Milk Fat Globule Epidermal Growth Factor 8 Coordinately Improve Remodeling After Myocardial Infarction via Local Delivery of Vascular Endothelial Growth Factor Heart failure in South America.Alternatively activated macrophages determine repair of the infarcted adult murine heart.How can we cure a heart "in flame"? A translational view on inflammation in heart failure.Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.Multiple cytokine biomarkers in heart failure.Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation.Immune modulation in heart failure: past challenges and future hopes.When are pro-inflammatory cytokines SAFE in heart failure?Ozone: a new therapeutic agent in vascular diseases.Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome.Latest drug developments in the field of cardiovascular disease.Inflammatory cytokines in heart failure: mediators and markers.The role of B-cells in heart failure Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure.The use of therapeutic apheresis in cardiovascular disease.Innate immunity and the failing heart: the cytokine hypothesis revisited.A Central Role for Monocyte-Platelet Interactions in Heart Failure.Where Does Inflammation Fit?The role of inflammation and cell death in the pathogenesis, progression and treatment of heart failure.Role of Inflammation in Heart Failure.How robust are clinical trials in heart failure?Autoantibody profiling on a plasmonic nano-gold chip for the early detection of hypertensive heart disease.Usefulness of cell-mediated immune function in risk stratification for patients with advanced heart failure.Moving beyond surrogate endpoints in cell therapy trials for heart disease.Effects of ozone blood treatment on the metabolite profile of human blood.Inflammation in chronic heart failure: what is familiar, what is unfamiliar?Relation between red cell distribution width and clinical outcome after surgery for congenital heart disease in children.Is There a Place for Ozone Therapy in Patients with Heart Failure?Combined Assessment of the Red Cell Distribution Width and B-type Natriuretic Peptide: A More Useful Prognostic Marker of Cardiovascular Mortality in Heart Failure Patients.Immune mechanisms in heart failure.

P2860

Q24650348-DB2C62EF-360E-48A9-968A-F0C5245422BB Q26745543-E799AF05-8A02-4C61-8ED5-0BBE7B4DDBCB Q28077186-099B00BD-036E-4EF9-8BC6-0420BDC5FC6E Q34031139-4D7ABFA2-3052-41BE-BF20-B8FC80599395 Q34390635-E50EBA45-034B-4DFE-A0E0-377A3A57FA29 Q34549960-A94CB0CA-741D-466D-B32F-A107EAD9BFA8 Q35595640-1943C938-1B8B-4B9D-9834-F804FC7C3953 Q35977353-5CFC792C-7C62-4116-BE04-89E358948120 Q36194239-1189ACC0-0BCD-48D1-B3FF-D6D08CBBE6B1 Q36617861-02413689-D01F-4568-858E-4C1CAFB5C3F3 Q36928523-5CF20C9F-9B4F-47DE-AFF7-8217BA41055C Q36951782-B72810FB-C31B-46C3-844D-0299C72A1BA5 Q37004826-8D43A89A-CF08-4750-A268-1D63A7A7E5A4 Q37090971-F1739996-8BDD-4CD0-AFAA-90EDBBF037FC Q37705430-7C12F2AD-F1EF-448B-B407-025E6854641A Q37775559-A3EE5679-8254-4D2F-964D-CBB126A76E69 Q37827408-A94F1E16-E6EF-4DA9-9759-4755210F48B0 Q37838085-B7C56D14-92C2-4C7E-8837-A7241B06B496 Q37858997-850885B9-0689-4187-9281-100A6F220710 Q37891878-03F45D87-969D-4E1D-BB47-BA7ACF7F5877 Q38000173-3DA3238A-D4CD-4614-A89A-4E4FB8D1F7CC Q38018808-8ED03A37-4847-43AB-94B2-561440257089 Q38091933-3FA2D1E6-2A5D-4845-8B35-00A6C677A71A Q38183314-A1D53ABF-E372-4858-990D-6FAF32227744 Q38203567-C73EF5BC-E63E-4857-8936-E332497FC7F6 Q38393039-14211277-D0E2-4065-968D-528F943C79DC Q38620927-DE707A2C-21E7-4005-BB6C-B20B30D56CCF Q38639570-778B9660-AFCF-4963-934D-1BE924CA0C19 Q38731483-13000E3D-674F-4DDB-AE53-C083D6C13E3E Q39255848-DC6E6426-194E-44DA-8A97-59740299BA26 Q39289642-8C0F1EC3-24F8-4AAC-ACDB-739B7D27C336 Q40153619-97E46C54-CACA-46B4-9104-911DA868DDBD Q40423463-4A0B648D-EA23-4BBB-A0E9-18C3ECEA683A Q41891677-D4C950BE-AC93-4B09-A299-A1E253E5068D Q43119644-2B64C73A-4C3B-4D6D-BDAC-75929E959530 Q43184066-43C1FC9E-9D10-460E-B11A-C67609D7A09D Q46691948-3A5C2D67-D43E-41B2-9882-57924F250D5A Q48157266-A7DCFCEA-E734-4BB6-81D0-32C142BBFD68 Q50055768-FC22439F-AC59-4AB1-9459-9CA311C27888 Q50168083-3CF12803-C1CC-4A59-ACC0-B2853460E3D8

P2860

Results of a non-specific immunomodulation therapy in chronic heart failure (ACCLAIM trial): a placebo-controlled randomised trial.

http://www.wikidata.org/entity/Q47968070

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Results of a non-specific immu ...... o-controlled randomised trial.

@en

Results of a non-specific immunomodulation therapy in chronic heart failure

@nl

type

label

Results of a non-specific immu ...... o-controlled randomised trial.

@en

Results of a non-specific immunomodulation therapy in chronic heart failure

@nl

prefLabel

Results of a non-specific immu ...... o-controlled randomised trial.

@en

Results of a non-specific immunomodulation therapy in chronic heart failure

@nl

P1433

Q47968070-49FCC0BB-D44C-4B50-8FED-B35527593F78

P1476

Q47968070-80F15E27-0B1B-4375-B9AF-2DA3A278A14B

P2093

Q47968070-18171B84-0738-43D7-B631-5BA380490554

Q47968070-2D27E48B-F6DB-4755-8E2A-75B8B1AE8B13

Q47968070-2D4F2A0D-A6DD-4BCD-B40E-FCE2632E8E1A

Q47968070-3E8B0205-82F2-49DA-8821-667BC3F0B702

Q47968070-428A7156-12D3-4881-A72E-A4DCE516E24B

Q47968070-5D406237-CD9D-478E-8768-7A72EABBE84F

Q47968070-5FEAAAAD-6686-4949-8EB3-34D26EC47B5D

Q47968070-6536D8ED-4392-427B-9A4E-884EAEF0B6A7

Q47968070-7C2607F2-734C-4CC6-AA6F-209FECF43B0B

Q47968070-96307227-81B5-40C8-9CED-F7745891BB9E

P304

Q47968070-15B3C9B2-AE74-4D30-8D6B-B4CD5121070F

P31

Q47968070-48F5C5F3-CD5D-4964-AD5A-417F2BDBB7CB

P356

Q47968070-D8CFE672-4D8B-4C70-87CB-B029BCB059FB

P407

Q47968070-86D067C3-B39B-4464-9741-2A3CFAD67988

P433

Q47968070-B2FE6943-18C5-4435-B0AB-F09189C132FB

P478

Q47968070-20A0CF78-BF7A-41D7-8BFB-CB23DD0D913A

P50

Q47968070-5A11BD41-4522-4559-91F8-9291EBEA9AE9

Q47968070-6A26F76E-6362-4CD1-82E2-DCE9D3F8403D

P577

Q47968070-929C4118-B746-4105-A902-E3E817F6904A

P698

Q47968070-8797203B-D3E3-413E-B82E-39CAC966A477

P921

Q47968070-90105D68-56EB-4794-907D-3F8A4DBEABB1

P356

S0140-6736(08)60134-8

P1433

P1476

Results of a non-specific immu ...... o-controlled randomised trial.

@en

P2093

Advanced Chronic Heart Failure ...... dulation Therapy Investigators

http://www.w3.org/2001/XMLSchema#string

Andre Keren

http://www.w3.org/2001/XMLSchema#string

Barry H Greenberg

http://www.w3.org/2001/XMLSchema#string

Bernhard R Winkelmann

http://www.w3.org/2001/XMLSchema#string

Craig M Pratt

http://www.w3.org/2001/XMLSchema#string

Francois Sestier

http://www.w3.org/2001/XMLSchema#string

Guillermo Torre-Amione

http://www.w3.org/2001/XMLSchema#string

James B Young

http://www.w3.org/2001/XMLSchema#string

Jan Erik Otterstad

http://www.w3.org/2001/XMLSchema#string

Jean Lucien Rouleau

http://www.w3.org/2001/XMLSchema#string

P304

228-236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0140-6736(08)60134-8

http://www.w3.org/2001/XMLSchema#string

P407

P433

9608

http://www.w3.org/2001/XMLSchema#string

P478

371

http://www.w3.org/2001/XMLSchema#string

P50

Piotr Ponikowski

Stefan D. Anker

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18207018

http://www.w3.org/2001/XMLSchema#string

P921